Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

Preview

Item Type:	Letter
Title:	Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al
Creators Name:	Immisch, L. and Papafotiou, G. and Popp, O. and Mertins, P. and Blankenstein, T. and Willimsky, G.
Keywords:	Glioma, HLA-A2 Antigen, Histones, Immunotherapy, Mutation
Source:	Journal for ImmunoTherapy of Cancer
ISSN:	2051-1426
Publisher:	BMJ Publishing Group
Volume:	11
Number:	3
Page Range:	e006784
Date:	14 March 2023
Official Publication:	https://doi.org/10.1136/jitc-2023-006784
PubMed:	View item in PubMed

Repository Staff Only: item control page

Download Statistics

Downloads per month over past year